These trials completed more than 12 months ago and should have reported results.

These trials are not yet due to report results: some are ongoing, some completed within the past 12 months.

These trials have problematic data on the registry. Details why »

Status Trial ID Title Completion date Category
Completed, but no date 2004-002539-25 Randomized phase II trial of second-line chemotherapy with oxaliplatin and docetaxel vs. docetaxel in patients with advanced non-small cell lung cancer (NSCLC) bad-data
Ongoing 2004-003996-35 randomized,double blind, placebo-controlled trial of the effect of treatment with 3 hypertonic salin solution on bronchiolitis not-yet-due
Completed, but no date 2004-004819-29 Use of Rituximab in the treatment of extensive chronic graft versus host disease after allogenic stem cells transplantation bad-data
Completed, but no date 2005-001457-16 RANDOMIZED, DOUBLE BLIND TRIAL MONTELUKAST VERSUS LEVOCETIRIZINE IN THE TREATMENT OF SEASONAL RHINITIS AND CONJUNCTIVITIS IN CHILDREN 6-14 YEARS OLD bad-data
Completed, but no date 2005-004442-14 A pilot clinical trial to evaluate the ability of pegylate r-metHg-CSF (Pegilgrastim) to accelerate haematology recovery of patients with Non-Hodgkins Lymphoma after High-dose chemiotherapy and autolo... bad-data
Completed, but no date 2005-004984-43 Randomized, double-blind, placebo controlled trial on the efficacy of montelukast in exercise-induced asthma in children bad-data
Ongoing 2005-006182-14 Intravitreal Bevacizumab Avastin, Roche, United Kingdom for exudative maculopathies not-yet-due
Ongoing 2006-003170-99 Evaluation of efficacy and safety of Intravitreal bevacizumab versus intravitreal bevacizumab combined with juxtascleral anecortave acetate for the treatment exudative age-related macular degeneration not-yet-due
Ongoing 2006-005011-10 LOW DOSE RITUXIMAB IN THE TREATMENT OF AUTOIMMUNE THROMBOCYTOPENIA. not-yet-due